Timothy Harris

Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.

Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom.

SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston.

Part of Leidos Holdings, Inc., SAIC-Frederick, Inc. provides technical solutions and services. The company is based in San Diego, CA. David Heimbrook has been the CEO of the company since 2011.

Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA.

Part of Spectrum Pharmaceuticals, Inc., Biogen-Idec Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is based in Gaithersburg, MD.

Part of Samsung Electronics Co., Ltd., Duran Audio BV is a Dutch company that manufactures and distributes audio equipment. The company is based in Zaltbommel, the Netherlands. Duran Audio was acquired by Harman International Industries, Inc., part of Samsung Electronics Co., Ltd. from March 13, 2017 on October 17, 2013 for $40.47 million.

Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom.